Preliminary results of a 68Ga‐PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision‐making

Preliminary results of a 68Ga‐PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision‐making

Background In this prospective study (NCT03443609), we investigated the impact of 68Ga‐PSMA‐11 PET‐CT on the treatment plan and therapeutic response obtained for patients with prostate cancer (PCa) presenting a recurrence with a low rising PSA. Methods One hundred thirty hormone‐naive (PSA

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Prostate 2019-09, Vol.79 (13), p.1514-1522
Hauptverfasser: Rousseau, Caroline, Le Thiec, Maelle, Ferrer, Ludovic, Rusu, Daniela, Rauscher, Aurore, Maucherat, Bruno, Frindel, Mathieu, Baumgartner, Pierre, Fleury, Vincent, Denis, Antoine, Morel, Agnes, Varmenot, Nicolas, Debeaupuis, Emilie, Campion, Loic, Kraeber‐Bodéré, Francoise
Format: Artikel
Sprache:eng
Schlagworte:
68Ga‐PSMA
biochemical recurrence
Decision making
impact on implemented management PSMA
Localization
Lymph nodes
Patients
PET/CT
Positron emission tomography
Prostate cancer
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background In this prospective study (NCT03443609), we investigated the impact of 68Ga‐PSMA‐11 PET‐CT on the treatment plan and therapeutic response obtained for patients with prostate cancer (PCa) presenting a recurrence with a low rising PSA. Methods One hundred thirty hormone‐naive (PSA
ISSN:0270-4137
1097-0045
DOI:10.1002/pros.23869